Transplant Diagnostics Market Is Projected to Gain $1,031 Million Value Globally, with Notable CAGR Value
"The non-molecular assay segment is reported to demonstrate a steady growth, due to advent of technological shift in the market. Molecular assays are expected to dominate the technology segment of the transplant diagnostics market, owing to the highly reliable results provided by these assays. Coupled with this, molecular assays used for performing transplant diagnostics procedures are equipped with highly sophisticated technology such as next-generation sequencing, which is current market trend."
View full press release